| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/17/2007 | EP1345501B1 Nutritional and therapeutical preparations having antioxidant activity |
| 01/17/2007 | EP1341793B1 Crf receptor antagonists and methods relating thereto |
| 01/17/2007 | EP1341531B1 Lactam compound to inhibit beta-amyloid peptide release or synthesis |
| 01/17/2007 | EP1337233B1 Use of at least a sulphonic amino derivative in a composition promoting skin peeling |
| 01/17/2007 | EP1336612B1 Novel carbapenem derivatives |
| 01/17/2007 | EP1309547B1 Crystalline and pure modafinil, and process of preparing the same |
| 01/17/2007 | EP1272160B1 Lipid-based drug delivery systems for topical application |
| 01/17/2007 | EP1268783B9 Antiangiogene Eigenschaften von Matin und Fragmenten oder Varianten davon |
| 01/17/2007 | EP1268444B1 2,4-di(hetero-)arylamino(-oxy)-5-substituted pyrmidines as antineoplastic agents |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1224188B1 Nasal delivery composition comprising the methane sulphonate salt of morphine and chitosan |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1130018B1 Drug dependence remedy |
| 01/17/2007 | EP1094822B1 Water miscible azalide solutions |
| 01/17/2007 | EP1070068B2 Granulatimide derivatives for use in cancer treatment |
| 01/17/2007 | EP1065945B1 Method for producing a fat mixture |
| 01/17/2007 | EP1063990B1 Use of a biochanin-enriched extract for the treatment of estrogen-associated disorders |
| 01/17/2007 | CN1898569A Method of therapy |
| 01/17/2007 | CN1898370A Fat composition |
| 01/17/2007 | CN1898249A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/17/2007 | CN1898247A Polycyclic agents for the treatment of respiratory syncytial virus infections |
| 01/17/2007 | CN1898244A Triazole derivatives as vasopressin antagonists |
| 01/17/2007 | CN1898243A Bicyclic heterocyclic p-38 kinase inhibitors |
| 01/17/2007 | CN1898240A Imidazopyrazine tyrosine kinase inhibitors |
| 01/17/2007 | CN1898239A Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 01/17/2007 | CN1898238A Oxazolidinone-quinolone hybrid antibiotics |
| 01/17/2007 | CN1898237A Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy |
| 01/17/2007 | CN1898235A Heterocyclic derivatives as gpcr receptor agonists |
| 01/17/2007 | CN1898232A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 01/17/2007 | CN1898231A Bipiperidinyl derivatives useful as inhibitors of chemokine receptors |
| 01/17/2007 | CN1898221A Modulators of atp-binding cassette transporters |
| 01/17/2007 | CN1898219A Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 01/17/2007 | CN1898217A Benzo'1,4-diazepin-2-one derivatives as phosphodiesterase pde2 inhibitors, preparation and therapeutic use thereof |
| 01/17/2007 | CN1898216A Amide derivatives |
| 01/17/2007 | CN1898215A 有丝分裂驱动蛋白抑制剂 Mitotic kinesin inhibitors |
| 01/17/2007 | CN1898214A Dicationic triaryl analogs as anti-protozoan agents |
| 01/17/2007 | CN1898212A Analogs of benzoquinone-containing ansamycins for the treatment of cancer |
| 01/17/2007 | CN1898211A Crystal form of quinoline compound and process for its production |
| 01/17/2007 | CN1898209A Pyridine carboxylic acid derivatives as glucokinase modulators |
| 01/17/2007 | CN1898208A Amide derivative and medicine |
| 01/17/2007 | CN1898206A Allosteric modulators of metabotropic glutamate receptors |
| 01/17/2007 | CN1898205A Indolinone derivatives and their use in treating disease-states such as cancer |
| 01/17/2007 | CN1898204A 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 01/17/2007 | CN1898203A Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 01/17/2007 | CN1898202A Anti-hypercholesterolemic compounds |
| 01/17/2007 | CN1898201A Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| 01/17/2007 | CN1898199A Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of alzheimer's disease |
| 01/17/2007 | CN1898198A Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 01/17/2007 | CN1898197A Novel compounds |
| 01/17/2007 | CN1897975A Nanoparticle compositions of water-soluble drugs for oral administration and preparation methods thereof |
| 01/17/2007 | CN1897974A Medicinal lipolysis of accumulations of fat |
| 01/17/2007 | CN1897973A Propagation agent and propagation method for natural killer cell |
| 01/17/2007 | CN1897972A Agents for treatment of glaucomatous retinopathy and optic neuropathy |
| 01/17/2007 | CN1897971A Cd40 antibody formulation and methods |
| 01/17/2007 | CN1897957A Chaperone-based therapy for niemann-pick disease |
| 01/17/2007 | CN1897956A Methods and compositions comprising thalidomide for treatment of fibromyalgia |
| 01/17/2007 | CN1897955A Glycerophospholipids containing omega-3 and omega-6 fatty acids |
| 01/17/2007 | CN1897954A Florfenicol prodrug having improved water solubility |
| 01/17/2007 | CN1897953A Anti-inflammatory agents |
| 01/17/2007 | CN1897952A Neutrophilia inhibitor |
| 01/17/2007 | CN1897951A Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 01/17/2007 | CN1897949A Combination therapy comprising the use of et-743 and paclitaxel for treating cancer |
| 01/17/2007 | CN1897948A Alkoxy substituted imidazoquinolines |
| 01/17/2007 | CN1897947A Muscarinic acetylcholine receptor antagonists field of the invention |
| 01/17/2007 | CN1897946A 1- 2' (1, 4'-biperidin-1'-yl)-1- (phenyl) -ethyl cyclohexanol derivatives as monoamine reuptake modulators for the treatment of visomotor symptoms |
| 01/17/2007 | CN1897945A Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain |
| 01/17/2007 | CN1897944A Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 01/17/2007 | CN1897943A Novel treatment of irritable bowel syndrome i |
| 01/17/2007 | CN1897942A Pharmaceutical compositions |
| 01/17/2007 | CN1897941A Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
| 01/17/2007 | CN1897940A Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same |
| 01/17/2007 | CN1897939A Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists |
| 01/17/2007 | CN1897938A Use of 1,3-diaza-dibenzo[e,h]azulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/17/2007 | CN1897937A 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline |
| 01/17/2007 | CN1897936A Cyclic guanidines, compositions containing such compounds and methods of use |
| 01/17/2007 | CN1897935A Use of rotigotine for treatment or prevention of dopaminergic neurone loss |
| 01/17/2007 | CN1897934A Use of substituted 2-aminotetralines for the preventative treatment of parkinson's disease |
| 01/17/2007 | CN1897933A Use of glucosidase inhibitors for therapy of mucovisidosis |
| 01/17/2007 | CN1897932A Composition for treatment of osteoarthritis containing apigenin as chindroregenerative agent |
| 01/17/2007 | CN1897931A Inhibitors of cathepsin s |
| 01/17/2007 | CN1897930A Compositions and methods for treating contracture |
| 01/17/2007 | CN1897929A Pharmaceutical composition comprising 5-methyl-2-(2'-chloro-6'-fluoroanilino)phenylacetic acid |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/17/2007 | CN1897927A Transdermal pharmaceutical spray formulations comprising a vp/va copolymer and a non-aqueous vehicle |
| 01/17/2007 | CN1897926A Pharmaceutical formulations of bisphosphonates |
| 01/17/2007 | CN1897925A Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses |
| 01/17/2007 | CN1897924A Drug coating providing high drug loading and methods for providing same |
| 01/17/2007 | CN1897923A 控释药物制剂 Controlled release pharmaceutical preparation |
| 01/17/2007 | CN1897922A Process for producing pellets for pharmaceutical compositions |
| 01/17/2007 | CN1897917A Suspension of loteprednol etabonate and tobramycin for topical ophthalmic use |
| 01/17/2007 | CN1897910A Antimicrobial compositions containing an aromatic carboxylic acid and a hydric solvent |
| 01/17/2007 | CN1897891A Gamma-tocopherol therapy for restenosis prevention |
| 01/17/2007 | CN1897890A Use of alginate matrices to control cell growth |
| 01/17/2007 | CN1897828A Health food, process for producing the same and dried matter or extract |
| 01/17/2007 | CN1897816A Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain |
| 01/17/2007 | CN1896270A Therapeutic and preventing methods for bone loss |
| 01/17/2007 | CN1896109A Alcohol-soluble Chinese-Angelica micromolecular polysaccharide, its preparation and use |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896100A Liver regenerated factor and its use |
| 01/17/2007 | CN1896095A Lucid ganoderma sugar peptide, its production and use |